NCT04581421

Brief Summary

The purpose of this study is to investigate dietary compositions effect on liverfat measured by magnetic resonance imaging.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 9, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

December 3, 2020

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2022

Completed
Last Updated

January 23, 2024

Status Verified

January 1, 2024

Enrollment Period

1.5 years

First QC Date

September 25, 2020

Last Update Submit

January 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Liverfat

    The effect of high-carbohydrate/low-fat vs low-carbohydrate/high-fat diet on change in MRS determined liver fat.

    (MRS Day -1 (before intervention starts), Day 5 (after diet intervention is completed)

Secondary Outcomes (4)

  • Glycogen

    (MRS Day -1 (before intervention starts), Day 5 (after diet intervention is completed)

  • fasting hepatic glucose output

    (Day 0 and Day 6 of the diet intervention)

  • fasting blood triacylglycerol concentration

    (Day 0 and Day 6 of the diet intervention)

  • Insulin clearance determined during steady state insulin infusion

    (Day 0 and Day 6 of the diet intervention)

Study Arms (2)

High Carb first

EXPERIMENTAL
Other: High Carb Low Fat DietOther: Low Carb High Fat Diet

Low Carb first

EXPERIMENTAL
Other: High Carb Low Fat DietOther: Low Carb High Fat Diet

Interventions

The participants will be randomized to a diet of low carb/ high fat og high carb/low fat

High Carb firstLow Carb first

The participants will be randomized to a diet of low carb/ high fat og high carb/low fat

High Carb firstLow Carb first

Eligibility Criteria

Age18 Years - 50 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy men being 18-50 years old.
  • Overweight (BMI 25-35)
  • Low to moderate physical activity level, defined as ≤ 1 weekly session of aerobic exercise.
  • Non-smokers
  • No use of medicine

You may not qualify if:

  • Fasting blood glucose indicating overt diabetes (≥7 mmol/l)
  • HbA1C \>48 mmol/mol
  • Fasting plasma triacylglycerol indicating dyslipidemia (≥2.2 mmol/l)
  • FIB-4 score \>1.45
  • Contraindications for MR-scan: abdominal height exceed limitations of the MR-scanner, pacemaker or other electronic device implanted, implanted metal devices, severe claustrophobia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amalie London

Hvidovre, Denmark

Location

Related Publications (1)

  • London A, Richter MM, Sjoberg KA, Wewer Albrechtsen NJ, Povazan M, Drici L, Schaufuss A, Madsen L, Oyen J, Madsbad S, Holst JJ, van Hall G, Siebner HR, Richter EA, Kiens B, Lundsgaard A, Bojsen-Moller KN. The impact of short-term eucaloric low- and high-carbohydrate diets on liver triacylglycerol content in males with overweight and obesity: a randomized crossover study. Am J Clin Nutr. 2024 Aug;120(2):283-293. doi: 10.1016/j.ajcnut.2024.06.006. Epub 2024 Jun 22.

MeSH Terms

Conditions

Non-alcoholic Fatty Liver DiseaseOverweightObesityMetabolic SyndromeDiabetes Mellitus

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System DiseasesOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Randomized diet intervention study in a cross over design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, MD, PhD

Study Record Dates

First Submitted

September 25, 2020

First Posted

October 9, 2020

Study Start

December 3, 2020

Primary Completion

June 15, 2022

Study Completion

June 15, 2022

Last Updated

January 23, 2024

Record last verified: 2024-01

Locations